text_1: CD44v6 is not associated with constitutive and reprogrammed cancer stem cells driving cancer metastasis.
text_2: Importantly, phosphatidylinositol 3-kinase (PI3K) inhibition selectively killed CD44v6 CR-CSCs and reduced metastatic growth.